Barr buyout drives Teva to 4Q loss

NEW YORK - Generic drugmaker Teva Pharmaceutical Industries Ltd. reported a loss today on hefty charges for the buyout of rival Barr Pharmaceuticals Inc. and a loss in financial assets.